Financial Times: "Ex-Google Venture Capitalist Turns up at Medtech’s TrialReach"

Eze Vidra joins medtech start-up as CIO, seven months after closure of Europe investment fund

TrialReach has hired Eze Vidra as its new Chief Innovation Officer, and the Financial Times have covered the story. 

"Eze Vidra, a leading venture capitalist, has become the latest big tech name to join TrialReach, a UK start-up that has thus far avoided the funding problems he says are being experienced by others following the Brexit vote."

Read more on the Financial Times. 

By
Lisa Brockway
On
September 23, 2026

© 2026 Antidote Technologies, Inc.